Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nasalmer is an isotonic sodium chloride solution primarily used for nasal irrigation and cleansing. Developed and marketed by Sanofi, it serves as a non-pharmacological aid to wash the nasal cavity, wounds, and eyes. As a simple saline solution, it does not possess a specific biological target or complex pharmacological mechanism of action; instead, it works through physical cleansing and maintaining moisture in the mucous membranes. It is typically used to relieve nasal congestion, remove allergens or irritants, and support overall nasal hygiene in both pediatric and adult populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nasalmer.